A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A269.3 KBAimmune Therapeutics, Inc.Feb 16, 4:14 PM ET·0001306923-21-000011
- 8-K258.2 KBAimmune Therapeutics, Inc.Oct 19, 5:05 PM ET·0001193125-20-272122
- SC 13D/A79.7 KBAimmune Therapeutics, Inc.Oct 13, 10:48 AM ET·0001193125-20-268119
- SC 13D/A97.0 KBAimmune Therapeutics, Inc.Aug 31, 6:47 AM ET·0001193125-20-235338
- 8-K841.2 KBAimmune Therapeutics, Inc.Aug 31, 6:08 AM ET·0001193125-20-235288
- 10-Q11.1 MBAimmune Therapeutics, Inc.Jul 30, 9:20 PM ET·0001564590-20-034973
- 8-K613.3 KBAimmune Therapeutics, Inc.Jul 30, 6:51 PM ET·0001564590-20-034776
- 8-K185.6 KBAimmune Therapeutics, Inc.May 28, 4:50 PM ET·0001564590-20-027348
- 10-Q9.5 MBAimmune Therapeutics, Inc.May 11, 4:14 PM ET·0001564590-20-024196
- 8-K506.9 KBAimmune Therapeutics, Inc.May 11, 4:09 PM ET·0001564590-20-024181
Insiders
10- ADELMAN DANIEL C MDChief Medical Officer
- Barrowcliffe Susan E.General Manager, Europe
- Behar GregoryDirector
- BJERKHOLT ERICChief Financial Officer
- Dallas Jayson Donald AlexanderDirector, President and CEO
- DILLY STEPHEN GEORGEDirector, President and CEO
- ENRIGHT PATRICK GDirector, 10% Owner
- FALBERG KATHRYN EDirector
- Foresite Capital Fund III, L.P.10% Owner
- Foresite Capital Fund II, L.P.10% Owner
Tickers
No tickers on record
Addresses
business
8000 MARINA BOULEVARD SUITE 300
BRISBANE, CA, 94005-1884
mailing
8000 MARINA BOULEVARD SUITE 300
BRISBANE, CA, 94005-1884
Former Names
- Allergen Research Corp2015-03-24